Want to see IN:FAIRCHEMOR full AI Analyst Report?
Top Page
Fairchem Organics Ltd
(FAIRCHEMOR)
Select Model
Select Model
Rating:51Neutral
Price Target:
₹733.00
▼(-4.32% Downside)
Action:Reiterated
Date:07/02/26
The score is primarily held back by weakening financial performance (sharp margin/ROE deterioration) and a demanding valuation (very high P/E). These negatives are partially offset by strong current price momentum with the stock trading above key moving averages and supported by positive MACD.
Positive Factors
Specialty oleochemical product mix
Fairchem’s focus on value-added oleochemical derivatives serving flavors, personal care and home care supports durable B2B demand. Specialized inputs and specification-driven sales create stickier customer relationships and product-mix levers that can sustain higher margins over the medium term.
Negative Factors
Sharp margin deterioration
Material margin compression over recent years signals persistent cost or pricing pressure and weaker product mix. Sustained low margins will reduce returns on capital, limit ability to fund growth internally and make the company more vulnerable to feedstock or pricing volatility.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialty oleochemical product mix
Fairchem’s focus on value-added oleochemical derivatives serving flavors, personal care and home care supports durable B2B demand. Specialized inputs and specification-driven sales create stickier customer relationships and product-mix levers that can sustain higher margins over the medium term.
Read all positive factors
Fairchem Organics Ltd (FAIRCHEMOR) vs. iShares MSCI India ETF (INDA)
Market Cap
₹8.87B
Dividend Yield1.07%
Average Volume (3M)1.36K
Price to Earnings (P/E)164.2
Beta (1Y)0.06
Revenue Growth-14.55%
EPS Growth-74.70%
CountryIN
Employees227
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)4.27
Shares Outstanding12,595,902
10 Day Avg. Volume3,155
30 Day Avg. Volume1,356
Financial Highlights & Ratios
PEG Ratio-1.36
Price to Book (P/B)2.13
Price to Sales (P/S)1.22
P/FCF Ratio24.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Fairchem Organics Ltd Business Overview & Revenue Model
Company Description
Fairchem Organics Limited, headquartered in Ahmedabad, India, was founded in 2019. This company specializes in the manufacturing and worldwide sale of sophisticated oleochemicals and key nutraceutical components. Its market reach extends across In...
How the Company Makes Money
Fairchem Organics makes money primarily by selling specialty chemical products to business customers (B2B). Its core revenue stream is product sales from its portfolio of oleochemical derivatives and related specialty chemicals, where earnings are...
Fairchem Organics Ltd Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
63
Positive
Cash Flow
52
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.60B | 5.38B | 6.21B | 6.47B | 6.42B |
| Gross Profit | 355.37M | 666.52M | 1.54B | 1.56B | 1.78B |
| EBITDA | 220.40M | 441.21M | 681.10M | 729.68M | 1.05B |
| Net Income | 55.41M | 219.74M | 405.00M | 435.01M | 679.06M |
Balance Sheet | |||||
| Total Assets | 3.91B | 4.02B | 3.34B | 3.42B | 3.24B |
| Cash, Cash Equivalents and Short-Term Investments | 12.26M | 12.86M | 84.00K | 838.00K | 83.00K |
| Total Debt | 837.82M | 630.32M | 73.18M | 501.68M | 620.30M |
| Total Liabilities | 1.28B | 997.98M | 443.77M | 831.48M | 919.26M |
| Stockholders Equity | 2.63B | 3.02B | 2.90B | 2.59B | 2.32B |
Cash Flow | |||||
| Free Cash Flow | 229.13M | -464.87M | 563.52M | 348.89M | 58.91M |
| Operating Cash Flow | 382.54M | -203.78M | 744.80M | 496.15M | 404.85M |
| Investing Cash Flow | -140.95M | -255.71M | -176.25M | -144.92M | -341.84M |
| Financing Cash Flow | -241.53M | 459.49M | -568.55M | -351.24M | -63.19M |
Fairchem Organics Ltd Technical Analysis
Positive
766.10
Price Trends
624.93
Positive
587.29
Positive
649.51
Positive
Market Momentum
31.96
Negative
61.61
Neutral
61.64
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FAIRCHEMOR, the sentiment is Positive. The current price of 766.1 is above the 20-day moving average (MA) of 659.50, above the 50-day MA of 624.93, and above the 200-day MA of 649.51, indicating a bullish trend. The MACD of 31.96 indicates Negative momentum. The RSI at 61.61 is Neutral, neither overbought nor oversold. The STOCH value of 61.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:FAIRCHEMOR.
Fairchem Organics Ltd Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹10.78B | 8.26 | ― | 0.82% | 13.96% | 343.65% | |
67 Neutral | ₹9.16B | 11.79 | ― | 0.38% | 7.53% | 36.87% | |
65 Neutral | ₹11.00B | 31.27 | ― | 0.26% | -13.58% | -10.91% | |
58 Neutral | ₹6.66B | 13.24 | ― | 1.23% | -4.84% | -8.30% | |
56 Neutral | ₹7.58B | 23.53 | ― | ― | 2.78% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | ₹8.87B | 164.23 | ― | 1.07% | -14.55% | -74.70% |
* General Sector Average
IN:FAIRCHEMOR
Fairchem Organics Ltd
704.25
-262.88
-27.18%
IN:AMNPLST
Amines & Plasticizers Ltd.
200.00
-47.00
-19.03%
IN:INDOAMIN
Indo Amines Limited
126.25
-31.05
-19.74%
IN:JAYAGROGN
Jayant Agro-Organics Limited
221.95
-28.50
-11.38%
IN:MANALIPETC
Manali Petrochemicals Limited
62.66
-4.20
-6.28%
IN:VALIANTORG
Valiant Organics Limited
270.25
-139.80
-34.09%
Fairchem Organics Ltd Corporate Events
Fairchem Organics Publishes Audited FY26 Results Extract in Newspapers
May 7, 2026
Fairchem Organics Ltd has reported that its Board of Directors approved the audited financial results for the quarter and full year ended 31 March 2026 at a meeting held on 6 May 2026. The company subsequently published an extract of these audited...
Fairchem Organics Schedules May 7 Call on FY26 Results
Apr 29, 2026
Fairchem Organics Ltd has scheduled an earnings conference call on 7 May 2026 at 3:30 p.m. IST to discuss its audited financial results for the quarter and full year ended 31 March 2026. The call, coordinated by external investor relations adviser...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.